M6P Therapeutics Email Format
Biotechnology ResearchUnited States11-50 Employees
M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders. We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes. This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.